nCD64 vs. Neutrophil/Lymphocyte Ratio for Predicting In-hospital Outcome in AE-COPD

NCT03146611 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 75

Last updated 2017-05-11

No results posted yet for this study

Summary

Neutrophil CD64 versus Neutrophil/Lymphocyte ratio (NLR) as markers predicting in-hospital outcome in acute exacerbation of COPD

Conditions

  • COPD Exacerbation
  • Copd

Interventions

DIAGNOSTIC_TEST

nCD64

neutrophil CD64

DIAGNOSTIC_TEST

Neutrophil/Lymphocyte Ratio

Neutrophil/ lymphocyte ratio

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2016-03-11
Primary Completion
2017-03-01
Completion
2017-04-20

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03146611 on ClinicalTrials.gov